HomeCN2 • FRA
add
Catalyst Pharmaceuticals Inc
Previous close
€20.83
Day range
€20.48 - €20.48
Year range
€13.55 - €24.00
Market cap
2.90B USD
Avg Volume
79.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 141.42M | 43.56% |
Operating expense | 56.26M | -0.05% |
Net income | 56.74M | 143.77% |
Net profit margin | 40.12 | 69.78% |
Earnings per share | 0.68 | 78.95% |
EBITDA | 72.83M | 99.22% |
Effective tax rate | 20.41% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 580.66M | 87.06% |
Total assets | 908.87M | 40.55% |
Total liabilities | 114.59M | 34.39% |
Total equity | 794.28M | — |
Shares outstanding | 121.98M | — |
Price to book | 3.20 | — |
Return on assets | 18.00% | — |
Return on capital | 20.73% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 56.74M | 143.77% |
Cash from operations | 60.04M | 88.08% |
Cash from investing | — | — |
Cash from financing | 3.06M | -97.83% |
Net change in cash | 63.10M | -63.48% |
Free cash flow | 46.87M | 84.32% |
About
Founded
2002
Headquarters
Website
Employees
181
